Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nature Communications|November 24, 2025
The sex-biased chromatin modifier SMC1A promotes autoimmunity by shaping inflammatory pathways in patients with SLEDespoina Kosmara, Sofia Papanikolaou, Chrysoula Stathopoulou, et al.
RMD Open|March 13, 2025
Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosusPanagiotis Garantziotis, Georgia Savina Moysidou, Noemin Kapsala, et al.
Cell Reports|November 14, 2019
Aryl Hydrocarbon Receptor Contributes to the Transcriptional Program of IL-10-Producing Regulatory B CellsChristopher J M Piper, Elizabeth C Rosser, Kristine Oleinika, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosusDionysis Nikolopoulos, George Sentis, Iasonas Kitsios, et al.
Cancer Immunology Research|April 6, 2021
Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid TumorsMaria Grigoriou, Aggelos Banos, Aikaterini Hatzioannou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2017
Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responsesSofia Tousa, Maria Semitekolou, Ioannis Morianos, et al.
RMD Open|June 24, 2026
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort studyKaterina Chavatza, Chrysoula G Gialouri, Konstantinos Drougkas, et al.
Annals of the Rheumatic Diseases|July 29, 2022
Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritisEleni Frangou, Panagiotis Garantziotis, Maria Grigoriou, et al.
Nature Immunology|December 18, 2019
An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasionAikaterini Hatzioannou, Aggelos Banos, Theodore Sakelaropoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2020
Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathwaysIoannis Morianos, Aikaterini I Trochoutsou, Gina Papadopoulou, et al.
Pageof 5